Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Southern California
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven dx of recurrent or metastatic breast cancer
Must have received at least 1 but not more than 3 prior chemotherapy regimens for recurrent or metastatic breast cancer. Patients who relapse within 12 months of completing adjuvant chemotherapy can only have had up to 2 prior regimens for metastatic disease. Patients who relapse within 12 months of completing adjuvant chemotherapy containing an anthracycline and a taxane, do not require prior chemotherapy for metastatic disease.
Unidimensionally measurable dz (by RECIST)
At least 18 yrs of age
SWOG PS 0-2
AGC greater than or equal to 1.5; platelets greater than or equal to 100,000; Hgb greater than or equal to 8.0
Total bilirubin less than or equal to 2 x uln; SGOT and/or SGPT and alk phos up to 2.5 x uln
Creatinine less than or equal to 2.0
Fully recovered from acute toxicities secondary to prior tx
Signed informed consent (including HIPAA authorization)
Peripheral neuropathy grade 0-1
You may not be if
Prior tx with gemcitabine or oxaliplatin. Prior tx with cisplatin or carboplatin allowed if completed \>12 mos prior to enrollment.
Underlying medical, psychiatric, or social conditions that would preclude patient from receiving tx
Peripheral neuropathy greater than or equal to Gr 2
\-
Clareo Health | Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
